Hepatitis Monthly

Published by: Kowsar

Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China

Wen Jia 1 , 2 , Xun Qi 1 , Yan-Yan Ji 2 , Yun-Hao Xun 3 , Hong Wang 2 , Wen-Hong Zhang 1 , 2 , Jian-Hua Yang 2 , Jin-Yu Wang 1 , Hao-Xiang Zhu 1 , Ri-Cheng Mao 1 , * and Ji-Ming Zhang 1 , 2 , *
Authors Information
1 Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China
2 Department of Infectious Diseases, Jing’An District Centre, Shanghai Hospital, Fudan University, Shanghai, China
3 Department of Liver Diseases, Xixi Hospital of Hangzhou, Zhejiang Chinese Medical University, Hangzhou, China
Corresponding Authors:
Article information
  • Hepatitis Monthly: August 2015, 15 (8); e29183
  • Published Online: August 30, 2015
  • Article Type: Research Article
  • Received: April 12, 2015
  • Revised: May 27, 2015
  • Accepted: July 7, 2015
  • DOI: 10.5812/hepatmon.29183

To Cite: Jia W, Qi X, Ji Y, Xun Y, Wang H, et al. Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China, Hepat Mon. 2015 ;15(8):e29183. doi: 10.5812/hepatmon.29183.

Abstract
Copyright: Copyright © 2015, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Backgrounds
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Garcia–Tsao G. Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology. 2001; 120(3): 726-48[DOI]
  • 2. Butterworth RF. Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol. 2000; 32(1 Suppl): 171-80[PubMed]
  • 3. Chu CM, Liaw YF. Hepatitis B virus-related cirrhosis: natural history and treatment. Semin Liver Dis. 2006; 26(2): 142-52[DOI][PubMed]
  • 4. Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis. 2003; 23(1): 47-58[DOI][PubMed]
  • 5. European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012; 57(1): 167-85[DOI][PubMed]
  • 6. European Association For The Study Of The L. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol. 2009; 50(2): 227-42[DOI][PubMed]
  • 7. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int. 2008; 2(3): 263-83[DOI][PubMed]
  • 8. Martinez-Noguera A, Montserrat E, Torrubia S, Villalba J. Doppler in hepatic cirrhosis and chronic hepatitis. Semin Ultrasound CT MR. 2002; 23(1): 19-36[PubMed]
  • 9. Fung J, Lai CL, Chan SC, But D, Seto WK, Cheng C, et al. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis. Am J Gastroenterol. 2010; 105(5): 1116-22[DOI][PubMed]
  • 10. Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology. 2005; 42(6): 1437-45[DOI][PubMed]
  • 11. Seto WK, Lee CF, Lai CL, Ip PP, Fong DY, Fung J, et al. A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B. PLoS One. 2011; 6(8)[DOI][PubMed]
  • 12. Zhang YG, Wang BE, Wang TL, Ou XJ. Assessment of hepatic fibrosis by transient elastography in patients with chronic hepatitis B. Pathol Int. 2010; 60(4): 284-90[DOI][PubMed]
  • 13. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. 2015;
  • 14. Jin W, Lin Z, Xin Y, Jiang X, Dong Q, Xuan S. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol. 2012; 12: 14[DOI][PubMed]
  • 15. Shoaei SD, Sali S, Karamipour M, Riahi E. Non-invasive histologic markers of liver disease in patients with chronic hepatitis B. Hepat Mon. 2014; 14(2)[DOI][PubMed]
  • 16. Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012; 142(6): 1293-1302 e4[DOI][PubMed]
  • 17. Cheng PN, Tsai HW, Chiu YC, Ho CH, Wu IC, Chang TT. Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B. J Clin Virol. 2013; 57(4): 323-30[DOI][PubMed]
  • 18. Kim YJ, Cho HC, Choi MS, Lee JH, Koh KC, Yoo BC, et al. The change of the quantitative HBsAg level during the natural course of chronic hepatitis B. Liver Int. 2011; 31(6): 817-23[DOI][PubMed]
  • 19. Seto WK, Wong DK, Fung J, Ip PP, Yuen JC, Hung IF, et al. High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B. PLoS One. 2012; 7(8)[DOI][PubMed]
  • 20. Xun YH, Zang GQ, Guo JC, Yu XL, Liu H, Xiang J, et al. Serum hepatitis B surface antigen quantification as a useful assessment for significant fibrosis in hepatitis B e antigen-positive hepatitis B virus carriers. J Gastroenterol Hepatol. 2013; 28(11): 1746-55[DOI][PubMed]
  • 21. Martinot-Peignoux M, Carvalho-Filho R, Lapalus M, Netto-Cardoso AC, Lada O, Batrla R, et al. Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naive, e antigen-positive patients. J Hepatol. 2013; 58(6): 1089-95[DOI][PubMed]
  • 22. Hong MZ, Huang WQ, Min F, Xu JC, Lin Z, Fang KN, et al. Enhanced HBsAg synthesis correlates with increased severity of fibrosis in chronic hepatitis B patients. PLoS One. 2014; 9(1)[DOI][PubMed]
  • 23. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38(2): 518-26[DOI][PubMed]
  • 24. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994; 19(6): 1513-20[PubMed]
  • 25. Liu XD, Wu JL, Liang J, Zhang T, Sheng QS. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients. World J Gastroenterol. 2012; 18(22): 2784-92[DOI][PubMed]
  • 26. Schmilovitz-Weiss H, Tovar A, Halpern M, Sulkes J, Braun M, Rotman Y, et al. Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection. J Viral Hepat. 2006; 13(10): 671-7[DOI][PubMed]
  • 27. Kim BK, Kim do Y, Park JY, Ahn SH, Chon CY, Kim JK, et al. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int. 2010; 30(4): 546-53[DOI][PubMed]
  • 28. Wang H, Xue L, Yan R, Zhou Y, Wang MS, Cheng MJ, et al. Comparison of FIB-4 and APRI in Chinese HBV-infected patients with persistently normal ALT and mildly elevated ALT. J Viral Hepat. 2013; 20(4)-10[DOI][PubMed]
  • 29. Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, et al. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis. 2008; 40(4): 267-74[DOI][PubMed]
  • 30. Zhu X, Wang LC, Chen EQ, Chen XB, Chen LY, Liu L, et al. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection. Dig Dis Sci. 2011; 56(9): 2742-9[DOI][PubMed]
  • 31. Zeng DW, Liu YR, Dong J, Zhu YY, Li YB, Chen J, et al. Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection. Mol Med Rep. 2015; 11(5): 3465-72[DOI][PubMed]
  • 32. Pollicino T, Amaddeo G, Restuccia A, Raffa G, Alibrandi A, Cutroneo G, et al. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. Hepatology. 2012; 56(2): 434-43[DOI][PubMed]
  • 33. Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol. 2010; 52(4): 508-13[DOI][PubMed]
  • 34. Liang LB, Zhu X, Yan LB, Du LY, Liu C, Chen LY, et al. Serum hepatitis B surface antigen titer and transient elastography in screening for insignificant fibrosis in HBeAg-positive chronic hepatitis B patients. Ther Clin Risk Manag. 2015; 11: 229-35[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader